Trials / Recruiting
RecruitingNCT05076110
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 188 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone | 5 mg tablets every 4 hours postoperatively as needed for pain control |
| DRUG | Ibuprofen | 800 mg three times a day for 2 weeks postoperatively for pain control; not to exceed 3200 mg/day |
| DRUG | Gabapentin | 300 mg three times a day for 5 days then wean off by day 10 postoperatively |
| DRUG | Acetaminophen | 1000 mg three times a day for up to 4 weeks postoperatively for pain control; not to exceed 4 grams per day |
| DRUG | Methocarbamol | 500 mg three times a week for 2 weeks postoperatively |
Timeline
- Start date
- 2022-04-07
- Primary completion
- 2026-03-01
- Completion
- 2026-04-01
- First posted
- 2021-10-13
- Last updated
- 2025-06-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05076110. Inclusion in this directory is not an endorsement.